A股異動丨仁東控股逼近漲停 實控人將變更為北京市海淀區國資委
格隆匯11月15日丨仁東控股(002647.SZ)逼近漲停,報16.69元,總市值93.45億元。

公司昨日收到國家市場監督管理總局出具的《經營者集中反壟斷審查不實施進一步審查決定書》。本次權益變動完成前,海科金集團未持有上市公司任何股份或股份對應的表決權。本次權益變動完成後,截至目前,海科金集團將通過股份託管的方式持有上市公司119,088,160股股份對應的表決權,占上市公司總股本的21.27%。通過《關於仁東控股股份有限公司的一致行動協議》,海科金集團及其一致行動人將合計控制上市公司29.93%的股份表決權。公司控股股東變更為海科金集團,實際控制人變更為北京市海淀區國資委。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.